Moffitt Cancer Center
A

Clinical Implications of COMBI-d and COMBI-v Trials on OS in Patients With Metastatic Melanoma

By Moffitt Cancer Center FEATURING Ahmad Tarhini
By Moffitt Cancer Center FEATURING Ahmad Tarhini
468 views
May 2, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
10:01
AAD 2024 Insights

AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma

Feat. V. Sondak
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
05:37
Melanoma Bridge 2023

COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…

Feat. R. Dummer
52:19
Winship Melanoma and Cutaneous Oncology Symposium

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Feat. S. Patel
20:55
2023 West Oncology Conference

2023 West Oncology Conference: Melanoma Updates

Feat. M. Mooradian
04:45
Sapna Patel

Optimal Duration of Neoadjuvant Treatment in Melanoma: What We Do No…

20:32
Melanoma Bridge 2023

Targeted Therapy in BRAF-Mutated Metastatic Melanoma

Feat. R. Dummer
13:31
Melanoma Bridge 2023

What Is the Best Initial Treatment for Unresectable Mucosal Melanoma…

Feat. J. Luke
17:32
Insights from 2023 Society for Melanoma Research Annual Meeting

2023 SMR Congress Insights: "DREAMseq Trial Final 2-year OS Dat…

Feat. M. Atkins
24:22
Total Health

2022 Sedona Melanoma Updates From ASCO: Overview and Treatment

Feat. K. Lewis
21:38
Penn Medicine Abramson Cancer Center

Updates in Systemic Therapy for Melanoma

Feat. T. Mitchell
13:20
Penn Medicine Abramson Cancer Center

Penn Medicine Updates in Oncology 2023: Melanoma

Feat. J. Cohen
27:29
Total Health

2023 ASCO® Direct Philadelphia: Melanoma Updates

Feat. M. Orloff
13:55
Northwestern Medicine Oncology and Hematology

Utilization of COMBI-APlus Data in Clinical Practice: Adapted Pyrexi…

Feat. S. Chandra
07:53
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "aTezolizumab, bevAcizumab, and Cobimetinib…

Feat. E. Burton
12:09
Omid Hamid

Evolving Management of Melanoma CNS Metastases and the Impact of COM…

25:21
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update

Treatment of Advanced Melanoma in 2023

Feat. K. Bollin
05:06
ASCO 2022 Conference Coverage

ASCO 2022 on RELATIVITY-047 Trial: Nivolumab + Relatlimab vs. Nivo i…

Feat. P. Rutkowski
15:38
Melanoma Bridge 2023

New Interesting Targets From Recent Melanoma Research

Feat. O. Hamid